When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in Sydney have uncovered how getting a booster shot in the same arm as your ...

Moderna was trying to use its know-how from COVID to invent a vaccine platform it could deploy rapidly against several types of influenza, including the H5N1 bird flu—a version of which, if you ...

The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising ...

including H5N1 bird flu. In the same statement, Moderna also announced that the new vaccine it had been developing against H5 influenza strains, mRNA-1018, had positive results after being tested ...

The Trump administration just canceled a $770 million contract with Moderna (MRNA.O), opens new tab to develop, opens new tab an avian flu vaccine and the rights to buy the jabs. For the price of ...

The deal, forged under the Biden administration, aimed to prepare for future flu pandemics by funding Moderna’s work on a fast-acting vaccine using mRNA technology. HealthDay News — The U.S.

U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company ... Moderna said in a statement Wednesday that the ...

Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S. Department of Health and Human Services canceled a contract with the ...

"We're seeing children die from flu at lots of different age groups who are eligible to be vaccinated but are not getting the vaccine. This is something that we know the vaccine may not always be ...

Photo by Joseph Prezioso/AFP via Getty Images/TNS U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback ... in a statement ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The new vaccine ...